White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously

Stock Market Updates Today: Sectorally, except for IT and pharma index, all the other indices ended with decent gains. Private, PSU Bank and financial indices closed 3% higher today.

Stocks to watch today on February 24: Coal India, Pfizer, SBI Cards, Tata Power, NTPC, UPL among others are the top stocks to watch out for in Wednesday's trading session

Stocks to watch today on February 8: Adani Enterprises, Britannia, PNB, BEML, Maruti, Ashoka Buildcon, Pfizer among others are the top stocks to watch out for in Monday's trading session

Last year in September, Novavax had announced its deal with Serum Institute in order to produce 2 billion doses of COVID-19 vaccines

Details on the size of the deal or the price per dose COVAX would pay were not immediately clear, but the sources said the allotment would likely be relatively small

Speaking during a news conference in Brussels on Friday, European Commission president Ursula von der Leyen said the agreement will double the amount of doses already ordered by the 27-nation bloc

There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine

The goal of COVAX is to deliver two billion doses of safe, effective vaccines that have passed regulatory approval and/or WHO prequalification by the end of 2021

Apple Inc has historically had an office-centric culture and Cook has also expressed his desire for staff to ultimately return to the office in several public speaking forums

GSK said phase 1/2 interim results showed an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years but there was an insufficient response in older adults

Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, but there is no question of \"cutting corners\", said Thomas Cueni, director-general of the IFPMA

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

A blow-by-blow account of how Indian vaccines are being readied

COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla

Coronavirus vaccine: PM Modi said that a digital platform is being created now that will eventually help in enrolling, tracking and reaching beneficiaries

Adar Poonawalla claimed there was no immediate concern about the safety of the Oxford vaccine, adding that early indicators have been positive. However, Poonawalla said it will take a year or two to be certain that the vaccine has long-term effect

India Stock Market Highlights Today: Global equities were negative today as worries about a surge in coronavirus cases and dwindling hopes for a U.S. stimulus package kept investors gloomy

Stocks to watch today on October 28: Hero MotoCorp, Bharti Airtel, Wipro, ICICI Prudential, Tata Motors among others are the top stocks to watch out for in Wednesday's trading session

India Stock Market Highlights Today: Global equities were mostly negative today as surging coronavirus cases and lack of clarity on the US stimulus package kept sentiments bearish